{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-087277","form_type":"8-K","ticker":"CWAN","cik":"0001866368","company_name":"Clearwater Analytics Holdings, Inc.","filed_at":"2025-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.256164+00:00","generated_at":"2026-05-23T10:37:04.344072+00:00","sec_items":["1.01","1.02","2.01","2.03","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Clearwater completes $1.5B acquisition of Enfusion, unifies front-to-back investment platform","bullets":["Acquisition valued at ~$1.5B; Enfusion holders receive $10.87/share (cash) or 0.4676 CWAN shares, subject to proration (52% cash/48% stock).","Clearwater secures new $800M term loan and $200M revolver from JPMorgan-led syndicate to fund deal and refinance existing debt.","Deal creates first single-instance, cloud-native platform for front, middle, and back-office investment operations, eliminating fragmented workflows.","Enfusion contributes 38% of revenue from Europe/Asia; Clearwater expands global footprint to 7 hubs including London, Mumbai, and Singapore.","Clearwater's earlier acquisition of BISTRO (private credit analytics) and pending Beacon acquisition further broaden platform capabilities."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-087277","json":"https://secwatch.observer/filing/0001193125-25-087277.json","markdown":"https://secwatch.observer/filing/0001193125-25-087277.md","text":"https://secwatch.observer/filing/0001193125-25-087277.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1866368/000119312525087277/0001193125-25-087277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1866368/000119312525087277/d926858d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T10:37:04.344072+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"aba3285a955298dc926de27dc167e6afd0a36fa5","claim":"Clearwater Analytics Holdings, Inc. completed an acquisition involving Enfusion, Inc. for $1,412,840,049.03 (closed 2025-04-21).","evidence_excerpt":"to the Closing Date, was $23.2440, which was less than $25.0133, (w) the Per Share Parent Stock Amount was deemed to be 0.2159, (x) the Aggregate Consideration was equal to $1,412,840,049.03, (y) the Aggregate Consideration Per Share was equal to $10.87 and (z) the Exchange Ratio was 0.4676. As the Per Share Cash Consideration option was oversubscribed, such election","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1866368/000119312525087277/0001193125-25-087277-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Enfusion, Inc."},{"label":"Consideration","value":"$1,412,840,049.03"},{"label":"Closing","value":"2025-04-21"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}